Skip to main content
. Author manuscript; available in PMC: 2021 Dec 10.
Published in final edited form as: J Control Release. 2020 Sep 30;328:710–721. doi: 10.1016/j.jconrel.2020.09.048

Figure 4.

Figure 4.

Viability and chondrogenic activity of MSCs encapsulated in PLL-loaded hydrogels. (A) DNA content normalized by the hydrogel weight (wet) at each time point. (B) sGAG content normalized by the DNA content. * represent statistically significant difference (p < 0.05) to the 2 h time point within the same study group. # represent statistically significant difference (p < 0.05) compared to the no PLL group within the same time point (n = 4 per time point, mean ± standard deviation).